tradingkey.logo
tradingkey.logo
Search

CapsoVision Inc

CV
Add to Watchlist
6.455USD
-0.845-11.58%
Close 05/15, 16:00ETQuotes delayed by 15 min
322.51MMarket Cap
LossP/E TTM

CapsoVision Inc

6.455
-0.845-11.58%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-11.58%

5 Days

-9.34%

1 Month

+19.54%

6 Months

+26.07%

Year to Date

-39.62%

1 Year

0.00%

TradingKey Stock Score of CapsoVision Inc

Currency: USD Updated: 2026-05-15

Key Insights

CapsoVision Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 121 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very low.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 10.50.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

CapsoVision Inc's Score

Industry at a Glance

Industry Ranking
121 / 206
Overall Ranking
277 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

CapsoVision Inc Highlights

StrengthsRisks
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 38.97% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 13.55M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 13.55M.
Fairly Valued
The company’s latest PE is -6.07, at a medium 3-year percentile range.
Held by PRFDX
Star Investor PRFDX holds 562.00 shares of this stock.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
10.500
Target Price
+43.84%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

CapsoVision Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

CapsoVision Inc Info

CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Ticker SymbolCV
CompanyCapsoVision Inc
CEOWang (Kang-Huai)
Websitehttps://www.capsovision.com/
KeyAI